nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.352	1	CiPCiCtD
Prednicarbate—Prednisone—prostate cancer	0.245	1	CrCtD
Prednicarbate—NR3C1—prostate cancer	0.153	1	CbGaD
Prednicarbate—NR3C1—Prednisone—prostate cancer	0.0334	1	CbGbCtD
Prednicarbate—Testolactone—Estrone—prostate cancer	0.0313	0.177	CrCrCtD
Prednicarbate—Ciclesonide—Prednisone—prostate cancer	0.0103	0.0584	CrCrCtD
Prednicarbate—Hydrocortamate—Prednisone—prostate cancer	0.00864	0.0489	CrCrCtD
Prednicarbate—Cortisone acetate—Prednisone—prostate cancer	0.00838	0.0474	CrCrCtD
Prednicarbate—Testolactone—Prednisone—prostate cancer	0.00813	0.046	CrCrCtD
Prednicarbate—Alclometasone—Prednisone—prostate cancer	0.00768	0.0434	CrCrCtD
Prednicarbate—Budesonide—Prednisone—prostate cancer	0.00747	0.0422	CrCrCtD
Prednicarbate—Amcinonide—Prednisone—prostate cancer	0.00747	0.0422	CrCrCtD
Prednicarbate—Desonide—Prednisone—prostate cancer	0.00728	0.0412	CrCrCtD
Prednicarbate—Flunisolide—Prednisone—prostate cancer	0.00728	0.0412	CrCrCtD
Prednicarbate—Clobetasol propionate—Prednisone—prostate cancer	0.00728	0.0412	CrCrCtD
Prednicarbate—Paramethasone—Prednisone—prostate cancer	0.0071	0.0401	CrCrCtD
Prednicarbate—Triamcinolone—Prednisone—prostate cancer	0.00676	0.0382	CrCrCtD
Prednicarbate—Mometasone—Prednisone—prostate cancer	0.00676	0.0382	CrCrCtD
Prednicarbate—Loteprednol—Prednisone—prostate cancer	0.00676	0.0382	CrCrCtD
Prednicarbate—Betamethasone—Prednisone—prostate cancer	0.0066	0.0373	CrCrCtD
Prednicarbate—Dexamethasone—Prednisone—prostate cancer	0.0066	0.0373	CrCrCtD
Prednicarbate—Rimexolone—Prednisone—prostate cancer	0.0066	0.0373	CrCrCtD
Prednicarbate—Methylprednisolone—Prednisone—prostate cancer	0.00632	0.0357	CrCrCtD
Prednicarbate—Prednisolone—Prednisone—prostate cancer	0.00618	0.035	CrCrCtD
Prednicarbate—Hydrocortisone—Prednisone—prostate cancer	0.00594	0.0336	CrCrCtD
Prednicarbate—Allergic contact dermatitis—Estradiol—prostate cancer	0.00076	0.0356	CcSEcCtD
Prednicarbate—NR3C1—urine—prostate cancer	0.000711	0.348	CbGeAlD
Prednicarbate—Telangiectasia—Prednisone—prostate cancer	0.000626	0.0293	CcSEcCtD
Prednicarbate—Acneiform eruption—Prednisone—prostate cancer	0.000584	0.0273	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—TMPRSS2—prostate cancer	0.00053	0.0364	CbGpPWpGaD
Prednicarbate—Skin atrophy—Prednisone—prostate cancer	0.000488	0.0229	CcSEcCtD
Prednicarbate—Skin striae—Prednisone—prostate cancer	0.000464	0.0217	CcSEcCtD
Prednicarbate—Atrophy—Prednisone—prostate cancer	0.000453	0.0212	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—HOXB13—prostate cancer	0.00045	0.031	CbGpPWpGaD
Prednicarbate—Dermatitis acneiform—Prednisone—prostate cancer	0.000432	0.0202	CcSEcCtD
Prednicarbate—Eruption—Estradiol—prostate cancer	0.000432	0.0202	CcSEcCtD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA3—prostate cancer	0.000396	0.0273	CbGpPWpGaD
Prednicarbate—Secondary infection—Epirubicin—prostate cancer	0.000392	0.0184	CcSEcCtD
Prednicarbate—Hypertrichosis—Prednisone—prostate cancer	0.000388	0.0182	CcSEcCtD
Prednicarbate—Secondary infection—Doxorubicin—prostate cancer	0.000363	0.017	CcSEcCtD
Prednicarbate—Leukoderma—Prednisone—prostate cancer	0.000347	0.0162	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—KLK3—prostate cancer	0.000341	0.0235	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—SPOCK1—prostate cancer	0.000341	0.0235	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—KLF15—prostate cancer	0.000341	0.0235	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA1—prostate cancer	0.000323	0.0222	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—KLK2—prostate cancer	0.000321	0.0221	CbGpPWpGaD
Prednicarbate—Eruption—Docetaxel—prostate cancer	0.000278	0.013	CcSEcCtD
Prednicarbate—Leukoderma—Epirubicin—prostate cancer	0.000271	0.0127	CcSEcCtD
Prednicarbate—Oedema—Estramustine—prostate cancer	0.000268	0.0126	CcSEcCtD
Prednicarbate—Dermatitis contact—Estradiol—prostate cancer	0.000262	0.0123	CcSEcCtD
Prednicarbate—Oedema—Abiraterone—prostate cancer	0.00026	0.0122	CcSEcCtD
Prednicarbate—Infection—Abiraterone—prostate cancer	0.000259	0.0121	CcSEcCtD
Prednicarbate—Oedema—Estrone—prostate cancer	0.000256	0.012	CcSEcCtD
Prednicarbate—NR3C1—prostate gland—prostate cancer	0.000255	0.125	CbGeAlD
Prednicarbate—Leukoderma—Doxorubicin—prostate cancer	0.000251	0.0118	CcSEcCtD
Prednicarbate—Oedema—Nilutamide—prostate cancer	0.000238	0.0111	CcSEcCtD
Prednicarbate—Oedema—Flutamide—prostate cancer	0.000237	0.0111	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—FOXA1—prostate cancer	0.000228	0.0157	CbGpPWpGaD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—prostate cancer	0.000227	0.0156	CbGpPWpGaD
Prednicarbate—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.000224	0.0105	CcSEcCtD
Prednicarbate—Pain—Estrone—prostate cancer	0.000219	0.0103	CcSEcCtD
Prednicarbate—NR3C1—seminal vesicle—prostate cancer	0.000216	0.106	CbGeAlD
Prednicarbate—Paraesthesia—Nilutamide—prostate cancer	0.000214	0.01	CcSEcCtD
Prednicarbate—Urticaria—Estrone—prostate cancer	0.000204	0.00953	CcSEcCtD
Prednicarbate—Pain—Nilutamide—prostate cancer	0.000203	0.00952	CcSEcCtD
Prednicarbate—Oedema—Cabazitaxel—prostate cancer	0.0002	0.00937	CcSEcCtD
Prednicarbate—Infection—Cabazitaxel—prostate cancer	0.000199	0.00931	CcSEcCtD
Prednicarbate—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000191	0.00895	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.00019	0.0131	CbGpPWpGaD
Prednicarbate—Pruritus—Estramustine—prostate cancer	0.00019	0.00888	CcSEcCtD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—RXRA—prostate cancer	0.000189	0.013	CbGpPWpGaD
Prednicarbate—Eruption—Epirubicin—prostate cancer	0.000188	0.00878	CcSEcCtD
Prednicarbate—NR3C1—epithelium—prostate cancer	0.000187	0.0919	CbGeAlD
Prednicarbate—Folliculitis—Epirubicin—prostate cancer	0.000184	0.00859	CcSEcCtD
Prednicarbate—Pain—Degarelix—prostate cancer	0.000182	0.00851	CcSEcCtD
Prednicarbate—Pruritus—Estrone—prostate cancer	0.000181	0.00848	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—LAMC1—prostate cancer	0.00018	0.0124	CbGpPWpGaD
Prednicarbate—Paraesthesia—Cabazitaxel—prostate cancer	0.00018	0.00842	CcSEcCtD
Prednicarbate—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000178	0.00831	CcSEcCtD
Prednicarbate—NR3C1—renal system—prostate cancer	0.000174	0.0853	CbGeAlD
Prednicarbate—Eruption—Doxorubicin—prostate cancer	0.000174	0.00812	CcSEcCtD
Prednicarbate—Oedema—Bicalutamide—prostate cancer	0.000172	0.00804	CcSEcCtD
Prednicarbate—Pain—Cabazitaxel—prostate cancer	0.000171	0.00801	CcSEcCtD
Prednicarbate—NR3C1—urethra—prostate cancer	0.000171	0.0837	CbGeAlD
Prednicarbate—Infection—Bicalutamide—prostate cancer	0.000171	0.00799	CcSEcCtD
Prednicarbate—Folliculitis—Doxorubicin—prostate cancer	0.00017	0.00795	CcSEcCtD
Prednicarbate—Rash—Estramustine—prostate cancer	0.000169	0.00791	CcSEcCtD
Prednicarbate—Dermatitis—Estramustine—prostate cancer	0.000169	0.00791	CcSEcCtD
Prednicarbate—Urticaria—Degarelix—prostate cancer	0.000169	0.0079	CcSEcCtD
Prednicarbate—Pruritus—Nilutamide—prostate cancer	0.000168	0.00788	CcSEcCtD
Prednicarbate—Pruritus—Flutamide—prostate cancer	0.000168	0.00784	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—KLF6—prostate cancer	0.000166	0.0115	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—LIFR—prostate cancer	0.000166	0.0115	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MT2A—prostate cancer	0.000165	0.0114	CbGpPWpGaD
Prednicarbate—Amcinonide—ANXA1—prostate cancer	0.000164	0.0732	CrCbGaD
Prednicarbate—Rash—Abiraterone—prostate cancer	0.000164	0.00769	CcSEcCtD
Prednicarbate—Dermatitis—Abiraterone—prostate cancer	0.000164	0.00768	CcSEcCtD
Prednicarbate—Rash—Estrone—prostate cancer	0.000162	0.00756	CcSEcCtD
Prednicarbate—Dermatitis—Estrone—prostate cancer	0.000161	0.00755	CcSEcCtD
Prednicarbate—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000158	0.0074	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—PENK—prostate cancer	0.000157	0.0108	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	0.000157	0.0108	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—prostate cancer	0.000155	0.0107	CbGpPWpGaD
Prednicarbate—Paraesthesia—Bicalutamide—prostate cancer	0.000154	0.00722	CcSEcCtD
Prednicarbate—Pruritus—Degarelix—prostate cancer	0.00015	0.00704	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	0.00015	0.0103	CbGpPWpGaD
Prednicarbate—Rash—Nilutamide—prostate cancer	0.00015	0.00702	CcSEcCtD
Prednicarbate—Dermatitis—Nilutamide—prostate cancer	0.00015	0.00702	CcSEcCtD
Prednicarbate—Rash—Flutamide—prostate cancer	0.000149	0.00699	CcSEcCtD
Prednicarbate—Dermatitis—Flutamide—prostate cancer	0.000149	0.00698	CcSEcCtD
Prednicarbate—Pain—Bicalutamide—prostate cancer	0.000147	0.00688	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—HNF1B—prostate cancer	0.000147	0.0101	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—BMP7—prostate cancer	0.000147	0.0101	CbGpPWpGaD
Prednicarbate—Oedema—Ethinyl Estradiol—prostate cancer	0.000145	0.0068	CcSEcCtD
Prednicarbate—Infection—Ethinyl Estradiol—prostate cancer	0.000144	0.00675	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—ID3—prostate cancer	0.000142	0.00974	CbGpPWpGaD
Prednicarbate—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000141	0.0066	CcSEcCtD
Prednicarbate—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000141	0.00659	CcSEcCtD
Prednicarbate—NR3C1—Nuclear Receptors—ESR2—prostate cancer	0.000139	0.00957	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—LEP—prostate cancer	0.000137	0.00942	CbGpPWpGaD
Prednicarbate—Urticaria—Bicalutamide—prostate cancer	0.000136	0.00639	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.000135	0.0602	CrCbGaD
Prednicarbate—Rash—Degarelix—prostate cancer	0.000134	0.00627	CcSEcCtD
Prednicarbate—Dermatitis—Degarelix—prostate cancer	0.000134	0.00627	CcSEcCtD
Prednicarbate—NR3C1—bone marrow—prostate cancer	0.000131	0.0645	CbGeAlD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—prostate cancer	0.000131	0.00901	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.000128	0.00882	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—prostate cancer	0.000125	0.00857	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—AR—prostate cancer	0.000123	0.00846	CbGpPWpGaD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—prostate cancer	0.000123	0.00846	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—prostate cancer	0.000122	0.0084	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—RXRA—prostate cancer	0.000122	0.00839	CbGpPWpGaD
Prednicarbate—Pruritus—Bicalutamide—prostate cancer	0.000122	0.00569	CcSEcCtD
Prednicarbate—Oedema—Goserelin—prostate cancer	0.000119	0.00559	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—NPPA—prostate cancer	0.000119	0.00818	CbGpPWpGaD
Prednicarbate—Infection—Goserelin—prostate cancer	0.000119	0.00556	CcSEcCtD
Prednicarbate—Oedema—Conjugated Estrogens—prostate cancer	0.000118	0.00554	CcSEcCtD
Prednicarbate—Infection—Conjugated Estrogens—prostate cancer	0.000118	0.0055	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—NCOA2—prostate cancer	0.000117	0.00802	CbGpPWpGaD
Prednicarbate—Urticaria—Ethinyl Estradiol—prostate cancer	0.000115	0.0054	CcSEcCtD
Prednicarbate—Dermatitis contact—Epirubicin—prostate cancer	0.000114	0.00534	CcSEcCtD
Prednicarbate—NR3C1—Circadian Clock—NCOA2—prostate cancer	0.000113	0.00779	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—ATF3—prostate cancer	0.000113	0.00775	CbGpPWpGaD
Prednicarbate—NR3C1—testis—prostate cancer	0.000112	0.0551	CbGeAlD
Prednicarbate—NR3C1—Nuclear Receptors—VDR—prostate cancer	0.00011	0.0076	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR2—prostate cancer	0.00011	0.00757	CbGpPWpGaD
Prednicarbate—Rash—Bicalutamide—prostate cancer	0.000108	0.00507	CcSEcCtD
Prednicarbate—Dermatitis—Bicalutamide—prostate cancer	0.000108	0.00506	CcSEcCtD
Prednicarbate—Paraesthesia—Goserelin—prostate cancer	0.000107	0.00502	CcSEcCtD
Prednicarbate—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000106	0.00497	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—prostate cancer	0.000105	0.00494	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—PTHLH—prostate cancer	0.000103	0.00712	CbGpPWpGaD
Prednicarbate—Pruritus—Ethinyl Estradiol—prostate cancer	0.000103	0.00481	CcSEcCtD
Prednicarbate—Pain—Goserelin—prostate cancer	0.000102	0.00478	CcSEcCtD
Prednicarbate—Pain—Conjugated Estrogens—prostate cancer	0.000101	0.00474	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	0.0001	0.00689	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—EGR1—prostate cancer	9.97e-05	0.00686	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—MIF—prostate cancer	9.9e-05	0.00681	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—NCOA1—prostate cancer	9.82e-05	0.00676	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—AR—prostate cancer	9.71e-05	0.00668	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—RXRA—prostate cancer	9.63e-05	0.00663	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—NCOA1—prostate cancer	9.54e-05	0.00656	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—prostate cancer	9.51e-05	0.00655	CbGpPWpGaD
Prednicarbate—Urticaria—Goserelin—prostate cancer	9.49e-05	0.00444	CcSEcCtD
Prednicarbate—Oedema—Estradiol—prostate cancer	9.47e-05	0.00443	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—EZH2—prostate cancer	9.42e-05	0.00648	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—AR—prostate cancer	9.42e-05	0.00648	CbGpPWpGaD
Prednicarbate—Infection—Estradiol—prostate cancer	9.41e-05	0.0044	CcSEcCtD
Prednicarbate—Urticaria—Conjugated Estrogens—prostate cancer	9.4e-05	0.0044	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—prostate cancer	9.4e-05	0.00647	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—RXRA—prostate cancer	9.34e-05	0.00643	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—PPARA—prostate cancer	9.31e-05	0.00641	CbGpPWpGaD
Prednicarbate—Rash—Ethinyl Estradiol—prostate cancer	9.15e-05	0.00428	CcSEcCtD
Prednicarbate—Dermatitis—Ethinyl Estradiol—prostate cancer	9.15e-05	0.00428	CcSEcCtD
Prednicarbate—NR3C1—Circadian Clock—RXRA—prostate cancer	9.07e-05	0.00624	CbGpPWpGaD
Prednicarbate—Oedema—Mitoxantrone—prostate cancer	8.83e-05	0.00413	CcSEcCtD
Prednicarbate—Infection—Mitoxantrone—prostate cancer	8.77e-05	0.0041	CcSEcCtD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—VDR—prostate cancer	8.73e-05	0.006	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—PRKACB—prostate cancer	8.72e-05	0.006	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—SIRT1—prostate cancer	8.59e-05	0.00591	CbGpPWpGaD
Prednicarbate—Paraesthesia—Estradiol—prostate cancer	8.51e-05	0.00398	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—TH—prostate cancer	8.47e-05	0.00583	CbGpPWpGaD
Prednicarbate—Pruritus—Goserelin—prostate cancer	8.45e-05	0.00396	CcSEcCtD
Prednicarbate—NR3C1—Nuclear Receptors—ESR1—prostate cancer	8.44e-05	0.00581	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—prostate cancer	8.44e-05	0.00581	CbGpPWpGaD
Prednicarbate—Pruritus—Conjugated Estrogens—prostate cancer	8.37e-05	0.00392	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	8.3e-05	0.00571	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	8.26e-05	0.00569	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—prostate cancer	8.22e-05	0.00566	CbGpPWpGaD
Prednicarbate—NR3C1—lymph node—prostate cancer	8.15e-05	0.0399	CbGeAlD
Prednicarbate—Pain—Estradiol—prostate cancer	8.1e-05	0.00379	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—EGR1—prostate cancer	7.98e-05	0.00549	CbGpPWpGaD
Prednicarbate—Paraesthesia—Mitoxantrone—prostate cancer	7.93e-05	0.00371	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—GJA1—prostate cancer	7.6e-05	0.00523	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—prostate cancer	7.55e-05	0.0052	CbGpPWpGaD
Prednicarbate—Pain—Mitoxantrone—prostate cancer	7.55e-05	0.00353	CcSEcCtD
Prednicarbate—Rash—Goserelin—prostate cancer	7.53e-05	0.00353	CcSEcCtD
Prednicarbate—Dermatitis—Goserelin—prostate cancer	7.53e-05	0.00352	CcSEcCtD
Prednicarbate—Urticaria—Estradiol—prostate cancer	7.53e-05	0.00352	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	7.5e-05	0.0334	CrCbGaD
Prednicarbate—Rash—Conjugated Estrogens—prostate cancer	7.46e-05	0.00349	CcSEcCtD
Prednicarbate—Dermatitis—Conjugated Estrogens—prostate cancer	7.46e-05	0.00349	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—AHR—prostate cancer	7.44e-05	0.00512	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—PPARA—prostate cancer	7.36e-05	0.00506	CbGpPWpGaD
Prednicarbate—Infection—Etoposide—prostate cancer	7.29e-05	0.00341	CcSEcCtD
Prednicarbate—NR3C1—Generic Transcription Pathway—ZNF160—prostate cancer	7.15e-05	0.00492	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—prostate cancer	7.08e-05	0.00487	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—prostate cancer	7.03e-05	0.00484	CbGpPWpGaD
Prednicarbate—Urticaria—Mitoxantrone—prostate cancer	7.01e-05	0.00328	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	7e-05	0.00481	CbGpPWpGaD
Prednicarbate—Hydrocortisone—ANXA1—prostate cancer	6.93e-05	0.0308	CrCbGaD
Prednicarbate—NR3C1—Circadian Clock—PPARA—prostate cancer	6.93e-05	0.00477	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—prostate cancer	6.93e-05	0.00477	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—HIF1A—prostate cancer	6.73e-05	0.00463	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—prostate cancer	6.71e-05	0.00462	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	6.71e-05	0.00462	CbGpPWpGaD
Prednicarbate—Pruritus—Estradiol—prostate cancer	6.7e-05	0.00314	CcSEcCtD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR1—prostate cancer	6.67e-05	0.00459	CbGpPWpGaD
Prednicarbate—Testolactone—CYP19A1—prostate cancer	6.61e-05	0.0294	CrCbGaD
Prednicarbate—Paraesthesia—Etoposide—prostate cancer	6.59e-05	0.00309	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL10—prostate cancer	6.59e-05	0.00453	CbGpPWpGaD
Prednicarbate—Dexamethasone—CYP3A43—prostate cancer	6.54e-05	0.0291	CrCbGaD
Prednicarbate—Pain—Etoposide—prostate cancer	6.28e-05	0.00294	CcSEcCtD
Prednicarbate—Oedema—Docetaxel—prostate cancer	6.1e-05	0.00286	CcSEcCtD
Prednicarbate—Infection—Docetaxel—prostate cancer	6.06e-05	0.00284	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	6.03e-05	0.00415	CbGpPWpGaD
Prednicarbate—Rash—Estradiol—prostate cancer	5.97e-05	0.0028	CcSEcCtD
Prednicarbate—Dermatitis—Estradiol—prostate cancer	5.97e-05	0.00279	CcSEcCtD
Prednicarbate—Oedema—Capecitabine—prostate cancer	5.91e-05	0.00276	CcSEcCtD
Prednicarbate—Infection—Capecitabine—prostate cancer	5.87e-05	0.00275	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—GSK3B—prostate cancer	5.86e-05	0.00404	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	5.86e-05	0.00403	CbGpPWpGaD
Prednicarbate—Urticaria—Etoposide—prostate cancer	5.83e-05	0.00273	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—NCOA2—prostate cancer	5.69e-05	0.00391	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—CREBBP—prostate cancer	5.67e-05	0.0039	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—BAX—prostate cancer	5.66e-05	0.00389	CbGpPWpGaD
Prednicarbate—Rash—Mitoxantrone—prostate cancer	5.57e-05	0.0026	CcSEcCtD
Prednicarbate—Dermatitis—Mitoxantrone—prostate cancer	5.56e-05	0.0026	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—HIF1A—prostate cancer	5.55e-05	0.00382	CbGpPWpGaD
Prednicarbate—Difluprednate—NR3C1—prostate cancer	5.53e-05	0.0246	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—GADD45A—prostate cancer	5.51e-05	0.00379	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—CREBBP—prostate cancer	5.5e-05	0.00379	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—PLAU—prostate cancer	5.5e-05	0.00378	CbGpPWpGaD
Prednicarbate—Paraesthesia—Docetaxel—prostate cancer	5.48e-05	0.00256	CcSEcCtD
Prednicarbate—Paraesthesia—Capecitabine—prostate cancer	5.3e-05	0.00248	CcSEcCtD
Prednicarbate—Oedema—Prednisone—prostate cancer	5.26e-05	0.00246	CcSEcCtD
Prednicarbate—Infection—Prednisone—prostate cancer	5.23e-05	0.00245	CcSEcCtD
Prednicarbate—Pain—Docetaxel—prostate cancer	5.22e-05	0.00244	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	5.21e-05	0.00359	CbGpPWpGaD
Prednicarbate—Pruritus—Etoposide—prostate cancer	5.19e-05	0.00243	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—ESR1—prostate cancer	5.18e-05	0.00356	CbGpPWpGaD
Prednicarbate—Dexamethasone—ANXA1—prostate cancer	5.17e-05	0.023	CrCbGaD
Prednicarbate—NR3C1—Circadian Clock—SERPINE1—prostate cancer	5.16e-05	0.00355	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—prostate cancer	5.14e-05	0.00354	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IL6—prostate cancer	5.11e-05	0.00352	CbGpPWpGaD
Prednicarbate—Desonide—NR3C1—prostate cancer	5.07e-05	0.0226	CrCbGaD
Prednicarbate—Pain—Capecitabine—prostate cancer	5.05e-05	0.00236	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—APC—prostate cancer	5.01e-05	0.00345	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—TBX5—prostate cancer	4.96e-05	0.00341	CbGpPWpGaD
Prednicarbate—Loteprednol—NR3C1—prostate cancer	4.89e-05	0.0217	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	4.85e-05	0.00334	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—MDM2—prostate cancer	4.81e-05	0.00331	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—NCOA1—prostate cancer	4.79e-05	0.0033	CbGpPWpGaD
Prednicarbate—Paraesthesia—Prednisone—prostate cancer	4.72e-05	0.00221	CcSEcCtD
Prednicarbate—Urticaria—Capecitabine—prostate cancer	4.69e-05	0.0022	CcSEcCtD
Prednicarbate—Rash—Etoposide—prostate cancer	4.63e-05	0.00217	CcSEcCtD
Prednicarbate—Dermatitis—Etoposide—prostate cancer	4.62e-05	0.00216	CcSEcCtD
Prednicarbate—Beclomethasone—CYP3A5—prostate cancer	4.62e-05	0.0206	CrCbGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	4.61e-05	0.00317	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—RXRA—prostate cancer	4.56e-05	0.00314	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—ESR2—prostate cancer	4.49e-05	0.00309	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—prostate cancer	4.49e-05	0.00309	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TH—prostate cancer	4.46e-05	0.00307	CbGpPWpGaD
Prednicarbate—Pruritus—Docetaxel—prostate cancer	4.32e-05	0.00202	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—EGR1—prostate cancer	4.2e-05	0.00289	CbGpPWpGaD
Prednicarbate—Hydrocortamate—NR3C1—prostate cancer	4.19e-05	0.0186	CrCbGaD
Prednicarbate—Halobetasol Propionate—NR3C1—prostate cancer	4.19e-05	0.0186	CrCbGaD
Prednicarbate—Urticaria—Prednisone—prostate cancer	4.18e-05	0.00196	CcSEcCtD
Prednicarbate—Pruritus—Capecitabine—prostate cancer	4.18e-05	0.00196	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—prostate cancer	4.14e-05	0.00285	CbGpPWpGaD
Prednicarbate—Cortisone acetate—NR3C1—prostate cancer	4.12e-05	0.0183	CrCbGaD
Prednicarbate—Oedema—Epirubicin—prostate cancer	4.12e-05	0.00193	CcSEcCtD
Prednicarbate—Infection—Epirubicin—prostate cancer	4.09e-05	0.00191	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	4.04e-05	0.00278	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	4e-05	0.00275	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	4e-05	0.00275	CbGpPWpGaD
Prednicarbate—Megestrol acetate—NR3C1—prostate cancer	3.97e-05	0.0177	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	3.97e-05	0.00273	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—LPL—prostate cancer	3.94e-05	0.00271	CbGpPWpGaD
Prednicarbate—Medroxyprogesterone Acetate—SHBG—prostate cancer	3.89e-05	0.0173	CrCbGaD
Prednicarbate—Budesonide—NR3C1—prostate cancer	3.89e-05	0.0173	CrCbGaD
Prednicarbate—Amcinonide—NR3C1—prostate cancer	3.89e-05	0.0173	CrCbGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	3.86e-05	0.00266	CbGpPWpGaD
Prednicarbate—Rash—Docetaxel—prostate cancer	3.85e-05	0.0018	CcSEcCtD
Prednicarbate—Dermatitis—Docetaxel—prostate cancer	3.84e-05	0.0018	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—prostate cancer	3.81e-05	0.00178	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	3.78e-05	0.0026	CbGpPWpGaD
Prednicarbate—Infection—Doxorubicin—prostate cancer	3.78e-05	0.00177	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	3.75e-05	0.00258	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—EP300—prostate cancer	3.75e-05	0.00258	CbGpPWpGaD
Prednicarbate—Rash—Capecitabine—prostate cancer	3.72e-05	0.00174	CcSEcCtD
Prednicarbate—Pruritus—Prednisone—prostate cancer	3.72e-05	0.00174	CcSEcCtD
Prednicarbate—Dermatitis—Capecitabine—prostate cancer	3.72e-05	0.00174	CcSEcCtD
Prednicarbate—Mometasone—NR3C1—prostate cancer	3.7e-05	0.0165	CrCbGaD
Prednicarbate—Paraesthesia—Epirubicin—prostate cancer	3.7e-05	0.00173	CcSEcCtD
Prednicarbate—Rimexolone—NR3C1—prostate cancer	3.66e-05	0.0163	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	3.6e-05	0.00248	CbGpPWpGaD
Prednicarbate—Pain—Epirubicin—prostate cancer	3.52e-05	0.00165	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	3.52e-05	0.00242	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—PPARA—prostate cancer	3.48e-05	0.0024	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	3.47e-05	0.00239	CbGpPWpGaD
Prednicarbate—Beclomethasone—NR3C1—prostate cancer	3.45e-05	0.0154	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	3.44e-05	0.00237	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—BAZ2A—prostate cancer	3.44e-05	0.00237	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—SSR2—prostate cancer	3.44e-05	0.00237	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ZNF160—prostate cancer	3.44e-05	0.00237	CbGpPWpGaD
Prednicarbate—Paraesthesia—Doxorubicin—prostate cancer	3.42e-05	0.0016	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—AR—prostate cancer	3.41e-05	0.0152	CrCbGaD
Prednicarbate—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	3.4e-05	0.00234	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	3.39e-05	0.00234	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—HIF1A—prostate cancer	3.38e-05	0.00233	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	3.36e-05	0.00231	CbGpPWpGaD
Prednicarbate—Alclometasone—NR3C1—prostate cancer	3.36e-05	0.0149	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	3.32e-05	0.00229	CbGpPWpGaD
Prednicarbate—Rash—Prednisone—prostate cancer	3.32e-05	0.00155	CcSEcCtD
Prednicarbate—Dermatitis—Prednisone—prostate cancer	3.31e-05	0.00155	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—LEP—prostate cancer	3.3e-05	0.00227	CbGpPWpGaD
Prednicarbate—Urticaria—Epirubicin—prostate cancer	3.27e-05	0.00153	CcSEcCtD
Prednicarbate—Flunisolide—NR3C1—prostate cancer	3.27e-05	0.0145	CrCbGaD
Prednicarbate—Clobetasol propionate—NR3C1—prostate cancer	3.27e-05	0.0145	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	3.26e-05	0.00224	CbGpPWpGaD
Prednicarbate—Pain—Doxorubicin—prostate cancer	3.26e-05	0.00152	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	3.24e-05	0.00223	CbGpPWpGaD
Prednicarbate—Paramethasone—NR3C1—prostate cancer	3.23e-05	0.0144	CrCbGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	3.17e-05	0.00218	CbGpPWpGaD
Prednicarbate—Ciclesonide—NR3C1—prostate cancer	3.17e-05	0.0141	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—HNRNPH1—prostate cancer	3.15e-05	0.00217	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	3.09e-05	0.00213	CbGpPWpGaD
Prednicarbate—Fluticasone Propionate—CYP3A5—prostate cancer	3.07e-05	0.0137	CrCbGaD
Prednicarbate—Methylprednisolone—NR3C1—prostate cancer	3.04e-05	0.0135	CrCbGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	3.03e-05	0.00209	CbGpPWpGaD
Prednicarbate—Urticaria—Doxorubicin—prostate cancer	3.03e-05	0.00142	CcSEcCtD
Prednicarbate—Clobetasol propionate—CYP1A1—prostate cancer	2.97e-05	0.0132	CrCbGaD
Prednicarbate—Dexamethasone—CYP17A1—prostate cancer	2.97e-05	0.0132	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—IRS1—prostate cancer	2.95e-05	0.00203	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NFIC—prostate cancer	2.93e-05	0.00201	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.92e-05	0.00201	CbGpPWpGaD
Prednicarbate—Pruritus—Epirubicin—prostate cancer	2.91e-05	0.00136	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.89e-05	0.00199	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	2.86e-05	0.00197	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—INS—prostate cancer	2.82e-05	0.00194	CbGpPWpGaD
Prednicarbate—Prednisolone—CYP2A6—prostate cancer	2.78e-05	0.0124	CrCbGaD
Prednicarbate—Hydrocortisone—SHBG—prostate cancer	2.76e-05	0.0123	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—RPN2—prostate cancer	2.75e-05	0.00189	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.75e-05	0.00189	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	2.75e-05	0.00189	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IGF1—prostate cancer	2.73e-05	0.00188	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	2.72e-05	0.00187	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.71e-05	0.00186	CbGpPWpGaD
Prednicarbate—Pruritus—Doxorubicin—prostate cancer	2.69e-05	0.00126	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	2.69e-05	0.00185	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	2.69e-05	0.00185	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	2.65e-05	0.00182	CbGpPWpGaD
Prednicarbate—Medroxyprogesterone Acetate—ESR1—prostate cancer	2.63e-05	0.0117	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—QARS—prostate cancer	2.61e-05	0.00179	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	2.6e-05	0.00179	CbGpPWpGaD
Prednicarbate—Betamethasone—CYP19A1—prostate cancer	2.59e-05	0.0115	CrCbGaD
Prednicarbate—Rash—Epirubicin—prostate cancer	2.59e-05	0.00121	CcSEcCtD
Prednicarbate—Dermatitis—Epirubicin—prostate cancer	2.59e-05	0.00121	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—SERPINE1—prostate cancer	2.59e-05	0.00178	CbGpPWpGaD
Prednicarbate—Triamcinolone—NR3C1—prostate cancer	2.57e-05	0.0114	CrCbGaD
Prednicarbate—Hydrocortamate—CYP3A4—prostate cancer	2.43e-05	0.0108	CrCbGaD
Prednicarbate—Rash—Doxorubicin—prostate cancer	2.4e-05	0.00112	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—prostate cancer	2.4e-05	0.00112	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	2.4e-05	0.00165	CbGpPWpGaD
Prednicarbate—Cortisone acetate—CYP3A4—prostate cancer	2.39e-05	0.0106	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	2.39e-05	0.00164	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—TBX5—prostate cancer	2.39e-05	0.00164	CbGpPWpGaD
Prednicarbate—Prednisone—NR3C1—prostate cancer	2.33e-05	0.0104	CrCbGaD
Prednicarbate—Medroxyprogesterone Acetate—NR3C1—prostate cancer	2.32e-05	0.0103	CrCbGaD
Prednicarbate—Fluticasone Propionate—NR3C1—prostate cancer	2.29e-05	0.0102	CrCbGaD
Prednicarbate—Budesonide—CYP3A4—prostate cancer	2.26e-05	0.01	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—EIF3H—prostate cancer	2.22e-05	0.00153	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	2.21e-05	0.00152	CbGpPWpGaD
Prednicarbate—Hydrocortisone—CYP3A5—prostate cancer	2.2e-05	0.00978	CrCbGaD
Prednicarbate—Prednisolone—NR3C1—prostate cancer	2.15e-05	0.00955	CrCbGaD
Prednicarbate—Prednisone—CYP2C19—prostate cancer	2.12e-05	0.00944	CrCbGaD
Prednicarbate—Betamethasone—NR3C1—prostate cancer	2.1e-05	0.00935	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	2.08e-05	0.00143	CbGpPWpGaD
Prednicarbate—Dexamethasone—CYP1B1—prostate cancer	2.06e-05	0.00915	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—CTNNB1—prostate cancer	2.03e-05	0.00139	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	2.02e-05	0.00139	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	2.01e-05	0.00138	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.98e-05	0.00136	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.95e-05	0.00134	CbGpPWpGaD
Prednicarbate—Alclometasone—CYP3A4—prostate cancer	1.95e-05	0.00865	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.9e-05	0.00131	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.9e-05	0.00131	CbGpPWpGaD
Prednicarbate—Flunisolide—CYP3A4—prostate cancer	1.89e-05	0.00843	CrCbGaD
Prednicarbate—Paramethasone—CYP3A4—prostate cancer	1.87e-05	0.00832	CrCbGaD
Prednicarbate—Ciclesonide—CYP3A4—prostate cancer	1.84e-05	0.00819	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.82e-05	0.00125	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—TET2—prostate cancer	1.81e-05	0.00124	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MBD2—prostate cancer	1.81e-05	0.00124	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.78e-05	0.00123	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RPL12—prostate cancer	1.77e-05	0.00122	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—STAT3—prostate cancer	1.77e-05	0.00121	CbGpPWpGaD
Prednicarbate—Methylprednisolone—CYP3A4—prostate cancer	1.76e-05	0.00785	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.75e-05	0.0012	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.75e-05	0.0012	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.68e-05	0.00115	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.66e-05	0.00115	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.66e-05	0.00114	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.64e-05	0.00113	CbGpPWpGaD
Prednicarbate—Hydrocortisone—NR3C1—prostate cancer	1.64e-05	0.0073	CrCbGaD
Prednicarbate—Dexamethasone—CYP3A5—prostate cancer	1.64e-05	0.00729	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.64e-05	0.00113	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—EIF3A—prostate cancer	1.63e-05	0.00112	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.63e-05	0.00112	CbGpPWpGaD
Prednicarbate—Dexamethasone—CYP2A6—prostate cancer	1.59e-05	0.00705	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.54e-05	0.00106	CbGpPWpGaD
Prednicarbate—Dexamethasone—CYP19A1—prostate cancer	1.51e-05	0.00672	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.51e-05	0.00104	CbGpPWpGaD
Prednicarbate—Triamcinolone—CYP3A4—prostate cancer	1.49e-05	0.00662	CrCbGaD
Prednicarbate—Triamcinolone—PTGS2—prostate cancer	1.46e-05	0.00648	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.37e-05	0.000943	CbGpPWpGaD
Prednicarbate—Prednisone—CYP3A4—prostate cancer	1.35e-05	0.006	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—RPL10—prostate cancer	1.34e-05	0.000925	CbGpPWpGaD
Prednicarbate—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	1.34e-05	0.00597	CrCbGaD
Prednicarbate—Fluticasone Propionate—CYP3A4—prostate cancer	1.33e-05	0.00592	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.32e-05	0.000908	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.27e-05	0.000877	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NPPA—prostate cancer	1.27e-05	0.000877	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.27e-05	0.000875	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MED12—prostate cancer	1.25e-05	0.000862	CbGpPWpGaD
Prednicarbate—Prednisolone—CYP3A4—prostate cancer	1.24e-05	0.00553	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—IL6—prostate cancer	1.23e-05	0.000849	CbGpPWpGaD
Prednicarbate—Dexamethasone—NR3C1—prostate cancer	1.22e-05	0.00544	CrCbGaD
Prednicarbate—Betamethasone—CYP3A4—prostate cancer	1.22e-05	0.00542	CrCbGaD
Prednicarbate—Betamethasone—PTGS2—prostate cancer	1.19e-05	0.00531	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	1.15e-05	0.000793	CbGpPWpGaD
Prednicarbate—Dexamethasone—CYP2E1—prostate cancer	1.13e-05	0.00501	CrCbGaD
Prednicarbate—Dexamethasone—CYP2C19—prostate cancer	1.11e-05	0.00496	CrCbGaD
Prednicarbate—Dexamethasone—CYP1A1—prostate cancer	1.11e-05	0.00494	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.07e-05	0.000733	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RPS19—prostate cancer	1.07e-05	0.000733	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—DNMT1—prostate cancer	1.02e-05	0.000701	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	1.01e-05	0.000695	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NCOA2—prostate cancer	1e-05	0.000688	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—EZH2—prostate cancer	9.86e-06	0.000679	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—PARP1—prostate cancer	9.65e-06	0.000664	CbGpPWpGaD
Prednicarbate—Hydrocortisone—CYP3A4—prostate cancer	9.51e-06	0.00423	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	9.47e-06	0.000651	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR2—prostate cancer	9.14e-06	0.000629	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—HSPA1A—prostate cancer	9.14e-06	0.000629	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NCOA1—prostate cancer	8.42e-06	0.00058	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—AR—prostate cancer	8.08e-06	0.000556	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RXRA—prostate cancer	8.01e-06	0.000551	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—SIRT1—prostate cancer	7.36e-06	0.000507	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—VDR—prostate cancer	7.26e-06	0.000499	CbGpPWpGaD
Prednicarbate—Dexamethasone—CYP3A4—prostate cancer	7.09e-06	0.00315	CrCbGaD
Prednicarbate—Dexamethasone—PTGS2—prostate cancer	6.94e-06	0.00309	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—ERCC2—prostate cancer	6.64e-06	0.000457	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—PPARA—prostate cancer	6.12e-06	0.000421	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	5.99e-06	0.000412	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR1—prostate cancer	5.54e-06	0.000382	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—CREBBP—prostate cancer	4.86e-06	0.000334	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—SERPINE1—prostate cancer	4.56e-06	0.000314	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MYC—prostate cancer	2.88e-06	0.000198	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—AKT1—prostate cancer	2e-06	0.000138	CbGpPWpGaD
